Retrieve available abstracts of 53 articles: HTML format
Single Articles
May 2025
NOURI HR, Schaunaman N, Kraft M, Numata M, et al Tollip deficiency enhances mitophagy and reduces STING activation in influenza A
virus-infected mice.
J Immunol. 2025 May 16:vkaf058. doi: 10.1093. PubMedAbstract available
April 2025
MADRID DMC, Gu W, Karim SJI, Lowke MT, et al Single-cell analysis of pig lung leukocytes and their response to influenza
infection and oseltamivir therapy.
J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093. PubMedAbstract available
HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al IRF4-regulated transcriptional and functional heterogeneity of lung-resident
CD11b+ cDC2 subsets during influenza virus infection.
J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093. PubMedAbstract available
DINANT S, Castille J, Deloizy C, Bruder E, et al The prion-family protein Doppel exerts a protective role during influenza virus
infection.
J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093. PubMedAbstract available
March 2025
RAO AS, Ugwu N, Onufer AP, Kumova O, et al Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal
murine influenza virus infection.
J Immunol. 2025 Mar 18:vkae053. doi: 10.1093. PubMedAbstract available
February 2025
WANG M, Liu C, Fan Q, Sun Y, et al Rapid clonal expansion and somatic hypermutation contribute to the fate of
SARS-CoV-2 broadly neutralizing antibodies.
J Immunol. 2025;214:278-289. PubMedAbstract available
January 2025
GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and
significantly enhances the efficacy of inactivated split vaccination when
coadministered.
J Immunol. 2025;214:104-114. PubMedAbstract available
QIAO P, Yue C, Peng W, Liu K, et al Precise motif and cross-presentation of coronavirus peptides by feline MHC class
I: implications for the mild infection of SARS-CoV-2.
J Immunol. 2025;214:115-129. PubMedAbstract available
November 2024
TONG X, Deng Y, Cizmeci D, Fontana L, et al Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated
and Inactivated Seasonal Influenza Vaccination.
J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956. PubMedAbstract available
DICK JK, Sangala JA, Krishna VD, Khaimraj A, et al NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in
Children.
J Immunol. 2024;213:1452-1466. PubMedAbstract available
October 2024
RAJU N, Kramer KJ, Cavallaro M, Diotti RA, et al Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific
Memory B Cell Response following Influenza Vaccination.
J Immunol. 2024 Oct 23:ji2400326. doi: 10.4049/jimmunol.2400326. PubMedAbstract available
September 2024
DRUSKOVIC M, Lucovnik M, Mesaric VA, Kavsek G, et al Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG
and IgA Antibody Profile at Delivery and 42 Days Postpartum.
J Immunol. 2024 Sep 11:ji2400055. doi: 10.4049/jimmunol.2400055. PubMedAbstract available
HOLDER KA, Ings DP, Fifield KE, Barnes DA, et al Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar
Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated
Cytotoxicity than Breakthrough Infection.
J Immunol. 2024 Sep 9:ji2400250. doi: 10.4049/jimmunol.2400250. PubMedAbstract available
IZADI A, Godzwon M, Soderlund Strand A, Schmidt T, et al Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated
Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo
Protection against JN.1 Due to Attenuated Virulence.
J Immunol. 2024;213:678-689. PubMedAbstract available
June 2024
HE Z, Li W, Zhang M, Huang M, et al RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the
RIG-I Signaling Pathway in Ducks.
J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540. PubMedAbstract available
LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al Chickens with a Truncated Light Chain Transgene Express Single-Domain H
Chain-Only Antibodies.
J Immunol. 2024;212:1744-1753. PubMedAbstract available
LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
J Immunol. 2024;212:1693-1705. PubMedAbstract available
May 2024
BOUCHER J, Gilbert C, Bose S, Tessier PA, et al S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
J Immunol. 2024;212:1523-1529. PubMedAbstract available
SAITO S, Bozorgmehr N, Sligl W, Osman M, et al The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected
Individuals with Severe Disease.
J Immunol. 2024;212:1540-1552. PubMedAbstract available
April 2024
BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2
Neutralization of Convalescent and Vaccinee Sera.
J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320. PubMedAbstract available
KUNDURA L, Cezar R, Ballongue E, Andre S, et al Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2
Infection: Consumption Rather than Primary Deficiency.
J Immunol. 2024;212:1105-1112. PubMedAbstract available
ABE K, Beer JC, Nguyen T, Ariyapala IS, et al Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory
Markers in a COVID-19 Cohort.
J Immunol. 2024;212:1244-1253. PubMedAbstract available
March 2024
LI W, Lin Y, Wang X, Yang H, et al Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral
Polymerase Complex and Facilitating Type I IFN Production.
J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613. PubMedAbstract available
READ KA, Amici SA, Farsi S, Cutcliffe M, et al PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center
Responses during Influenza Virus Infection.
J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270. PubMedAbstract available
AL-AHMAD A Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are
Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of
Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
J Immunol. 2024;212:753. PubMed
MAINO A, Amen A, Plumas J, Bouquet L, et al Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for
the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
J Immunol. 2024;212:825-833. PubMedAbstract available
February 2024
TANDON P, Abrams ND, Avula LR, Carrick DM, et al Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
J Immunol. 2024;212:505-512. PubMedAbstract available
BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting
Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
J Immunol. 2024;212:523-528. PubMedAbstract available
DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against
Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and
Syrian Golden Hamster Models.
J Immunol. 2024;212:576-585. PubMedAbstract available
KAMMANN T, Gorin JB, Parrot T, Gao Y, et al Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of
Heterogeneous Functional Anomalies.
J Immunol. 2024;212:389-396. PubMedAbstract available
November 2023
LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza
Vaccines to Promote T Cell Responses.
J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343. PubMedAbstract available
EVANS JP, Liu SL Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming
Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
J Immunol. 2023;211:1459-1467. PubMedAbstract available
October 2023
MA W, Loving CL, Driver JP From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in
Pigs.
J Immunol. 2023;211:1187-1194. PubMedAbstract available
DIAZ FE, McGill JL Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions
and Future Directions Using the Calf Model of Bovine RSV Disease.
J Immunol. 2023;211:1180-1186. PubMedAbstract available
NOORUZZAMAN M, Diel DG Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally
Susceptible Animal Species.
J Immunol. 2023;211:1195-1201. PubMedAbstract available
ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al Relationship of Heterologous Virus Responses and Outcomes in Hospitalized
COVID-19 Patients.
J Immunol. 2023;211:1224-1231. PubMedAbstract available
September 2023
LUCKE J, Heinrich F, Malsy J, Meins N, et al Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
J Immunol. 2023;211:1052-1061. PubMedAbstract available
August 2023
SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al The Emerging Role of MAIT Cell Responses in Viral Infections.
J Immunol. 2023;211:511-517. PubMedAbstract available
CAO L, Hui X, Xu T, Mao H, et al The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by
Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799. PubMedAbstract available
July 2023
YU H, Worrall LJ, Berger T, Petric M, et al Identification of an optimized Receptor-Binding Domain Subunit Vaccine against
SARS-CoV-2.
J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282. PubMedAbstract available
LAW JC, Watts TH Considerations for Choosing T Cell Assays during a Pandemic.
J Immunol. 2023;211:169-174. PubMedAbstract available
PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88
Independently of the IL-17 Receptor.
J Immunol. 2023;211:252-260. PubMedAbstract available
June 2023
CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in
Adult Patients with Immune-Mediated Inflammatory Diseases.
J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190. PubMedAbstract available
MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein
Protects K18-hACE2 Mice against Viral Challenge.
J Immunol. 2023;210:1925-1937. PubMedAbstract available
PAIDI RK, Jana M, Raha S, Mishra RK, et al Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral
Entry: Implications for COVID-19.
J Immunol. 2023;210:1938-1949. PubMedAbstract available
NAM H, Koh JY, Jung JH, Jeong H, et al Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell
Population in Patients with Severe and Mild COVID-19.
J Immunol. 2023;210:1687-1699. PubMedAbstract available
May 2023
PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid
Immunity to SARS-CoV-2.
J Immunol. 2023;210:1236-1246. PubMedAbstract available
March 2023
FINN CM, Dhume K, Prokop E, Strutt TM, et al STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic
STAT4 Engagement Maximizes Their Antiviral Impact.
J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407. PubMedAbstract available
HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted
Influenza Virus Vaccine Immunity.
J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026. PubMedAbstract available
VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T
Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931. PubMedAbstract available
ZHAO Y, Xiao W, Wu Y, Fan W, et al Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct
Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune
Escape.
J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243. PubMedAbstract available
SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained
Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297. PubMedAbstract available
February 2023
QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses
following SARS-CoV-2 Vaccination.
J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920. PubMedAbstract available